Tear Fluid Protein Test Shows Promise for Brain Tumor Detection

Researchers at the University of Manchester are developing a minimally invasive test that analyzes tear fluid proteins to identify biomarkers for brain tumors. Initial results indicate the test can differentiate between individuals with and without brain tumors, but it remains in early research stages and requires validation before clinical use. This could provide a simpler screening method compared to current diagnostic procedures.